China Universal Asset Management Company’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Buy |
20,804
+40
| +0.2% | +$375 | 0.02% | 314 |
|
|
2025
Q1 | $148K | Sell |
20,764
-832
| -4% | -$5.92K | 0.01% | 336 |
|
|
2024
Q4 | $252K | Buy |
21,596
+2,059
| +11% | +$24K | 0.02% | 310 |
|
|
2024
Q3 | $401K | Buy |
19,537
+8,204
| +72% | +$169K | 0.04% | 239 |
|
|
2024
Q2 | $254K | Sell |
11,333
-7,141
| -39% | -$160K | 0.04% | 211 |
|
|
2024
Q1 | $508K | Buy |
18,474
+8,119
| +78% | +$223K | 0.06% | 179 |
|
|
2023
Q4 | $316K | Buy |
10,355
+8,092
| +358% | +$247K | 0.06% | 170 |
|
|
2023
Q3 | $71.6K | Buy |
2,263
+1,108
| +96% | +$35K | 0.02% | 216 |
|
|
2023
Q2 | $47.1K | Sell |
1,155
-37
| -3% | -$1.51K | 0.01% | 200 |
|
|
2023
Q1 | $44.4K | Buy |
1,192
+238
| +25% | +$8.87K | 0.02% | 159 |
|
|
2022
Q4 | $33.3K | Buy |
954
+88
| +10% | +$3.07K | 0.01% | 151 |
|
|
2022
Q3 | $48K | Buy |
866
+712
| +462% | +$39.5K | 0.02% | 123 |
|
|
2022
Q2 | $8K | Hold |
154
| – | – | ﹤0.01% | 88 |
|
|
2022
Q1 | $11K | Hold |
154
| – | – | ﹤0.01% | 79 |
|
|
2021
Q4 | $18K | Buy |
+154
| New | +$18K | ﹤0.01% | 82 |
|